Lysosomal And Rare Disorders Research And Treatment Center Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2014 | 152,334 | 157,699 | −5,365 | -1.3 | — |
| 2015 | 195,193 | 218,436 | −23,243 | -2.2 | — |
| 2016 | 375,235 | 350,671 | 24,564 | -0.5 | 22% |
| 2019 | 1,956,593 | 1,919,918 | 36,675 | 2.3 | 39% |
| 2020 | 1,934,480 | 2,201,912 | −267,432 | 0.5 | 57% |
| 2021 | 2,664,551 | 2,093,309 | 571,242 | 3.9 | 52% |
| 2022 | 3,020,151 | 2,474,219 | 545,932 | 5.9 | 43% |
| 2023 | 3,351,390 | 3,676,714 | −325,324 | 2.9 | 32% |
In its most recent public year (2023), this organization spent $325,324 more than it brought in. Its reserves stood at about 2.9 months of spending, up from -1.3 in 2014. Staff pay was 32% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works